title: [The meaning of the expression of PCNA and c-erbB-2 in the hyperplasia of laryngeal epithelium].
abstract: OBJECTIVE
  This study was performed to examine the relationship between PCNA and c-erbB-2 expression and histological diagnosis.
  
  
  METHODS
  The percentages of PCNA-positive nuclei (PCNA index) were evaluated in biopsies of 10 with epithelial simple hyperplasia, 26 with dysplasia and 30 with squamous carcinoma by immunohistochemical staining.
  
  
  RESULTS
  The PCNA indices were 6.64%, 29.36% and 62.67% respectively. There were significant statistic correlation between these indices and their histological gradies of lesions (P < 0.01). C-erbB-2 was not positive in all of dysplastic lesion and weak in carcinoma (20%).
  
  
  CONCLUSIONS
  The PCNA activity in dysplastic lesions of laryngeal premalignancis is higher than that in simple hyperplastic lesions but lower than that in carcinoma. The severe dysplasia with high PCNA indices should be treated clinically as the early invasive carcinom. The method should be regarded as a useful adjunct to traditional histological techniques with allowing more objective grading of epithelial hyperplastic lesions of larynx. There was no relationship between c-erbB-2 expression and histolotical diagnosis of hyperplastic lesions.
authors.affiliation: Department of Pathology, Affiliated Hospital,  Nanjing Railway Medical University, Nanjing 210009.
authors.forename: Q
authors.initials: Q
authors.lastname: Yao
authors.forename: X
authors.initials: X
authors.lastname: Lu
authors.forename: Z
authors.initials: Z
authors.lastname: Huang
authors.forename: Y
authors.initials: Y
authors.lastname: Cao
authors.forename: J
authors.initials: J
authors.lastname: Jiang
mesh_terms: D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000473:pathology; D005260:Female; D006801:Humans; D006965:Hyperplasia / Q000378:metabolism / Q000473:pathology; D007820:Laryngeal Mucosa / Q000378:metabolism / Q000473:pathology*; D007822:Laryngeal Neoplasms / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011230:Precancerous Conditions / Q000473:pathology; D018809:Proliferating Cell Nuclear Antigen / Q000096:biosynthesis*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis*
chemical_list: D018809:Proliferating Cell Nuclear Antigen; D018719:Erb-b2 Receptor Tyrosine Kinases